Susquehanna International Group
VBIO

Susquehanna International Group’s Valion Bio VBIO Stock Holding History

Susquehanna International Group’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,639
Closed -$21.2K – 14112
2025
Q4 		$21.2K Buy
+14,639
New +$33.4K ﹤0.01% 11945
2024
Q4 		– Sell
-927
Closed -$3.93K – 13217
2024
Q3 		$3.93K Buy
+927
New +$5.6K ﹤0.01% 11765
2023
Q3 		– Sell
-17
Closed -$3.09K – 12979
2023
Q2 		$3.09K Buy
17
+9
+113% +$1.93K ﹤0.01% 11849
2023
Q1 		$1.93K Buy
+8
New +$5.61K ﹤0.01% 12379

Other funds holding VBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Susquehanna International Group's VBIO Position: Q1 2026 in Review

Susquehanna International Group sold out of Valion Bio (VBIO) in Q1 2026, closing a stake of 14,639 shares — an estimated $21.2K sold.

Susquehanna International Group first reported a position in VBIO in Q1 2023 and held it in 4 quarters. The position peaked at $21.2K in Q4 2025. 9 funds tracked by Wall St. Rank hold VBIO as of Q1 2026.

  • Susquehanna International Group reported no remaining Valion Bio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 14,639 Valion Bio shares in Q1 2026, an estimated $21.2K.
  • Susquehanna International Group first reported a position in Valion Bio in Q1 2023 and held it in 4 quarters.
  • Susquehanna International Group's Valion Bio position peaked at $21.2K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Valion Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.